Mesoblast Ltd
F:LWBA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mesoblast Ltd
F:LWBA
|
AU |
|
Unico Silver Ltd
OTC:USLRF
|
AU |
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
US |
|
Inpixon
NASDAQ:XTIA
|
US |
|
K
|
Keurig Dr Pepper Inc
XMUN:DP5
|
US |
|
Franchise Brands PLC
LSE:FRAN
|
UK |
|
E
|
Enel SpA
F:ENL
|
IT |
Wall St Price Targets
LWBA Price Targets Summary
Mesoblast Ltd
According to Wall Street analysts, the average 1-year price target for LWBA is 6.13 EUR with a low forecast of 4.87 EUR and a high forecast of 8.04 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LWBA's stock price target?
Price Target
6.13
EUR
According to Wall Street analysts, the average 1-year price target for LWBA is 6.13 EUR with a low forecast of 4.87 EUR and a high forecast of 8.04 EUR.
What is the Revenue forecast for Mesoblast Ltd?
Projected CAGR
117%
Over the last 13 years, the compound annual growth rate for Revenue has been -6%. The projected CAGR for the next 6 years is 117%.
What is the Gross Profit forecast for Mesoblast Ltd?
Projected CAGR
192%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -2%. The projected CAGR for the next 3 years is 192%.
